We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products
News

Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products

Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products
News

Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

“We are delighted that Kirkstall have decided to offer Alvetex scaffold at the heart of their 3D Quasi-Vivo platform” commented Richard Rowling, Commercial Director at Reinnervate. “Alvetex scaffold is becoming the industry standard for scientists who need to retain the native structure and functionality of cells to better mimic in-vivo biological models” he added.

The two companies aim to launch the new joint product at the Kirkstall-sponsored 'Advances in in-vitro cell culture’ meeting in Utrecht on 22-23 May 2012.
www.invitrom.org/kirkstall/kirks.html

Malcolm Wilkinson, CEO of Kirkstall Ltd said, “life scientists are beginning to realise that perfusion based cell culture systems can significantly improve the biological relevance of in- vitro cell based assays. The Quasi-Vivo system already helps many leading laboratories improve the predictive accuracy of their ADMET studies. The early data we have that combines perfusion based cell culture with 3D cell growth shows stunning differences when compared to traditional 2D approaches.”

Advertisement